2022 Critical Care Pharmacy Preparatory Review and Recertification Course -- Pharmacokinetics/Pharmacodynamics, Pulmonary Disorders I, Pulmonary Disorders II, Infectious Diseases II, Fluids, Electrolytes, Acid-Base Disorders, and Nutrition Support

Saturday, April 23, 2022 from 12:30 PM to 5:30 PM CDT
at Academic and Research Building: Second Floor, Room 223
Available for 5.25 hours of CPE credit
Activity Number: 0217-0000-22-090-L01-P

The Critical Care Pharmacy Preparatory Review and Recertification Course is ideal for pharmacy professionals who are preparing for the Board of Pharmacy Specialties (BPS) Critical Care Pharmacy Specialty Certification Examination, for Board Certified Critical Care Pharmacists (BCCCPs) seeking recertification through continuing education, and for those seeking a self-paced review and refresher of critical care pharmacy topics.

Developed and presented by nationally recognized pharmacy faculty, the course content provides a comprehensive review of the knowledge domains covered in the critical care pharmacy specialty. Using a case-based approach, the course strongly emphasizes the thought processes needed to solve patient care problems in each therapeutic area.

Learning Objectives

1. Describe the changes in critically ill patients that alter drug absorption.
2. Explain how critical illness affects drug distribution.
3. Depict the effects of changing hepatic blood flow, intrinsic activity, and protein binding on drug metabolism.
4. Differentiate between different critically ill patient populations and the expected pharmacokinetic (PK) changes.
5. Incorporate the PK changes in a critically ill patient into the design and evaluation of an appropriate drug regimen.
6. Identify the desired pharmacodynamic variables associated with efficacy in select drugs.
7. Evaluate the role of pharmacologic management options in acute respiratory distress syndrome (ARDS).
8. Review clinical practice guidelines pertaining to ARDS.
9. Recommend an evidence-based approach for nonpharmacologic therapy in managing critically ill patients with ARDS.
10. Evaluate key variables and commonly used modes for treatment with mechanical ventilation.
11. Assess appropriateness of drug therapy for endotracheal intubation, including agents for premedication, induction, and neuromuscular blockade.
12. Design a treatment plan for a CF exacerbation.
13. Compare treatment strategies for pulmonary hypertension (PH) using the clinical classifications of PH.
14. Identify classifications and risk factors for increased severity of asthma exacerbation.
15. Outline a treatment plan for patients with acute respiratory failure caused by asthma exacerbation.
16. Recognize evidence-based treatment options for acute exacerbations of chronic obstructive pulmonary disease (COPD).
17. Compose a plan to incorporate quality metrics (e.g., prevention of catheter-associated urinary tract infections and catheter-related bloodstream infections) into pre- and postsurgical care.
18. Identify key members of, common strategies, and tools (including biomarkers and rapid diagnostic tests) used by an antimicrobial stewardship team.
19. Provide empiric antibiotic therapy recommendations for critically ill patients with community-acquired or health care􀂱associated meningitis.
20. Evaluate therapeutic options for the treatment of multidrug-resistant pathogens in the intensive care unit (ICU).
21. Devise an optimal treatment plan for critically ill immunocompromised patients with infectious diseases.
22. Describe normal fluid requirements, and identify common patient conditions that alter fluid needs and homeostasis.
23. Assess common electrolyte disorders in critically ill patients, and develop an appropriate treatment plan.
24. Identify acid-base disorders, differentiate between the causative factors, and construct an appropriate treatment algorithm.
25. Specify the appropriate route (parenteral or enteral) of nutrition administration, energy and protein needs, and key micronutrients to be provided to a critically ill patient.
26. Develop an appropriate assessment of the tolerance, safety, and efficacy of an enteral or parenteral nutrition regimen.

Pharmacokinetics/Pharmacodynamics 12:30 PM to 1:20 PM Speakers Speaker: Joseph M. Swanson, Pharm.D., FCCP Professor of Clinical Pharmacy and Translational Science University of Tennessee Health Science Center College of Pharmacy Memphis, Tennessee View Biography Swanson

Pulmonary Disorders I 1:20 PM to 2:10 PM Speakers Speaker: Mitchell Buckley, Pharm.D., FCCP Clinical Pharmacy Specialist, Banner University Medical Center Phoenix, Phoenix, Arizona View Biography Buckley

Pulmonary Disorders II 2:20 PM to 3:20 PM Speakers Speaker: Grace E. Benanti, Pharm.D., BCCCP Critical Care Clinical Pharmacist Loyola University Medical Center Chicago, Illinois View Biography Benanti

Infectious Diseases II 3:20 PM to 4:10 PM Speakers Speaker: Gabrielle Gibson, Pharm.D., BCCCP, BCPS Clinical Specialist, Surgical/Trauma/Burn ICU Barnes-Jewish Hospital Saint Louis, Missouri View Biography Gibson

Fluids, Electrolytes, Acid-Base Disorders, and Nutrition Support 4:10 PM to 5:30 PM Speakers Speaker: Diana Wells Mulherin, Pharm.D., FCCM, BCCCP, BCNSP Clinical Pharmacy Specialist - Nutrition Support Vanderbilt University Medical Center Nashville, Tennessee View Biography Wells Mulherin